Health Catalyst, Inc. (NASDAQ:HCAT) Insider Linda Llewelyn Sells 2,005 Shares

Health Catalyst, Inc. (NASDAQ:HCAT) insider Linda Llewelyn sold 2,005 shares of the business’s stock in a transaction that occurred on Monday, April 15th. The stock was sold at an average price of $6.11, for a total value of $12,250.55. Following the completion of the transaction, the insider now directly owns 126,226 shares in the company, valued at $771,240.86. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

Health Catalyst Stock Up 1.7 %

Shares of HCAT traded up $0.09 during midday trading on Wednesday, reaching $5.63. 585,279 shares of the stock were exchanged, compared to its average volume of 616,548. Health Catalyst, Inc. has a 52 week low of $5.51 and a 52 week high of $14.37. The company has a current ratio of 4.42, a quick ratio of 4.42 and a debt-to-equity ratio of 0.62. The company’s 50 day moving average is $8.04 and its two-hundred day moving average is $8.48. The company has a market capitalization of $329.40 million, a P/E ratio of -2.66 and a beta of 1.29.

Health Catalyst (NASDAQ:HCAT) last issued its quarterly earnings data on Thursday, February 22nd. The company reported ($0.21) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.27) by $0.06. The firm had revenue of $75.08 million during the quarter, compared to analysts’ expectations of $73.67 million. Health Catalyst had a negative return on equity of 12.19% and a negative net margin of 39.92%. On average, sell-side analysts anticipate that Health Catalyst, Inc. will post -0.47 earnings per share for the current year.

Institutional Investors Weigh In On Health Catalyst

Hedge funds have recently made changes to their positions in the stock. Fairfield Bush & CO. purchased a new stake in shares of Health Catalyst during the 1st quarter worth $25,000. Point72 Hong Kong Ltd purchased a new stake in shares of Health Catalyst during the 1st quarter worth $33,000. Macquarie Group Ltd. purchased a new stake in shares of Health Catalyst during the 2nd quarter worth $26,000. Tower Research Capital LLC TRC raised its stake in Health Catalyst by 165.1% in the third quarter. Tower Research Capital LLC TRC now owns 3,118 shares of the company’s stock valued at $32,000 after buying an additional 1,942 shares during the last quarter. Finally, Advisor Group Holdings Inc. raised its stake in Health Catalyst by 86.3% in the first quarter. Advisor Group Holdings Inc. now owns 5,324 shares of the company’s stock valued at $137,000 after buying an additional 2,467 shares during the last quarter. 85.00% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on HCAT shares. KeyCorp reaffirmed a “sector weight” rating on shares of Health Catalyst in a report on Wednesday, April 10th. Evercore ISI decreased their price objective on Health Catalyst from $11.00 to $10.00 and set an “outperform” rating on the stock in a report on Friday, February 23rd. Guggenheim raised Health Catalyst from a “neutral” rating to a “buy” rating and set a $14.00 target price on the stock in a research report on Friday, January 26th. Piper Sandler reissued an “overweight” rating and set a $15.00 target price (down previously from $17.00) on shares of Health Catalyst in a research report on Friday, February 23rd. Finally, Canaccord Genuity Group cut their target price on Health Catalyst from $12.00 to $11.00 and set a “buy” rating on the stock in a research report on Friday, February 23rd. Four investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $12.10.

Health Catalyst Company Profile

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.